Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Completed · Phase 3

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Key facts

Study ID

NCT00549289

Run by

Sirion Therapeutics, Inc.

Last updated by the study team

2007-10-25

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of dry eye syndrome

You may not qualify if…

• Intraocular or refractive surgery in the study eye within 3 months prior to study start
• Unwilling to discontinue use of contact lenses during the study
• Pregnancy or lactation

Where it is running

• Clayton Eye Center — Morrow, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.